Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Therapeutics    crawled date : 2022 - 11 - 07    save search

Orchard Therapeutics to Webcast Conference Call of Third Quarter 2022 Financial Results
Published: 2022-11-07 (Crawled : 19:00) - biospace.com/
ORTX | $16.7 0.0% 370K twitter stocktwits trandingview |
Health Technology
| | O: -4.58% H: 5.7% C: 2.46%

conference therapeutics financial results
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2022 Financial Results
Published: 2022-11-07 (Crawled : 19:00) - biospace.com/
MRSN | $2.88 -10.28% -11.07% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -4.51% H: 4.58% C: -7.78%

therapeutics financial update results
Incyte And Mirati Therapeutics Enter Into Clinical Trial Collaboration and Supply Agreement to Evaluate INCB99280 and Adagrasib in Patients with KRASG12C-Mutated Solid Tumors
Published: 2022-11-07 (Crawled : 18:00) - biospace.com/
MRTX | $58.7 -0.17% 0.34% 0 twitter stocktwits trandingview |
Health Technology
| | O: 0.79% H: 0.0% C: -5.85%
INCY | $51.74 0.17% 0.14% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.25% H: 0.46% C: -2.05%

incb9928 collaboration trial therapeutics tumors agreement
Amicus Therapeutics Provides EU Regulatory Update for AT-GAA
Published: 2022-11-07 (Crawled : 18:00) - globenewswire.com
FOLD 4 | $10.54 -1.59% -1.81% 1.8M twitter stocktwits trandingview |
Health Technology
| | O: -6.92% H: 11.16% C: 9.56%

therapeutics
The global digital therapeutics market is projected to reach USD 17.7 billion by 2027 from USD 4.5 billion in 2022, at a CAGR of 31.6%
Published: 2022-11-07 (Crawled : 15:00) - prnewswire.com
TDOC 4 | $13.73 -0.07% 0.95% 6.9M twitter stocktwits trandingview |
Health Services
| | O: 0.84% H: 1.56% C: -1.27%

global therapeutics market
Endonovo Therapeutics Issues Corporate Update
Published: 2022-11-07 (Crawled : 14:20) - globenewswire.com
ENDV | $0.0028 158.07% 74K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -3.75% H: 0.0% C: 0.0%

therapeutics update
Better Therapeutics to Release Third Quarter 2022 Financial Results and Provide Business Update on November 14, 2022
Published: 2022-11-07 (Crawled : 13:20) - biospace.com/
BTTX | $0.0078 30.0% -65.02% 890K twitter stocktwits trandingview |
| | O: 0.01% H: 2.97% C: -0.01%

therapeutics financial update results
Akero Therapeutics to Present Late-Breaking Oral and Poster presentations on EFX Today at AASLD’s The Liver Meeting® 2022Phase 2b HARMONY study presentation selected for inclusion in the Best of the Liver meeting in the NASH/NAFLD category
Published: 2022-11-07 (Crawled : 13:20) - biospace.com/
AKRO | $20.26 -3.52% -3.81% 630K twitter stocktwits trandingview |
Health Technology
| | O: 2.39% H: 2.39% C: -3.12%

meeting liver therapeutics presentation today study
Spero Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
Published: 2022-11-07 (Crawled : 13:20) - globenewswire.com
SPRO | $1.42 -1.05% -1.77% 110K twitter stocktwits trandingview |
Health Technology
| | O: 1.59% H: 2.34% C: 1.04%

report therapeutics financial update results
Repare Therapeutics to Participate in Two Upcoming Investor Conferences
Published: 2022-11-07 (Crawled : 13:00) - biospace.com/
RPTX 4 | $3.3 -1.79% -1.82% 73K twitter stocktwits trandingview |
Health Technology
| | O: 0.14% H: 0.0% C: -1.18%

therapeutics
Akero Therapeutics to Present Late-Breaking Oral and Poster presentations on EFX Today at AASLD’s The Liver Meeting® 2022
Published: 2022-11-07 (Crawled : 13:00) - ir.akerotx.com
AKRO | $20.26 -3.52% -3.81% 630K twitter stocktwits trandingview |
Health Technology
| | O: 2.39% H: 2.39% C: -3.12%

meeting liver therapeutics today
Amicus Therapeutics Announces Third Quarter 2022 Financial Results and Corporate Updates
Published: 2022-11-07 (Crawled : 13:00) - biospace.com/
FOLD 4 | $10.54 -1.59% -1.81% 1.8M twitter stocktwits trandingview |
Health Technology
| | O: -6.92% H: 11.16% C: 9.56%

therapeutics financial results
Axsome Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-07 (Crawled : 13:00) - biospace.com/
AXSM | $71.17 -2.61% -2.6% 580K twitter stocktwits trandingview |
Health Technology
| | O: -4.94% H: 8.4% C: 4.7%

therapeutics financial update results
Entrada Therapeutics Reports Third Quarter 2022 Financial Results
Published: 2022-11-07 (Crawled : 13:00) - biospace.com/
TRDA | $12.43 -3.57% -2.79% 39K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -0.23% H: 0.0% C: -9.82%

therapeutics financial results
F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research
Published: 2022-11-07 (Crawled : 13:00) - globenewswire.com
FSTX | $7.12 0.0% 0 twitter stocktwits trandingview |
Health Technology
| | O: 0.88% H: 0.0% C: -5.44%

fs118 research trial therapeutics cancer publication phase 1
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
Published: 2022-11-07 (Crawled : 13:00) - globenewswire.com
RLAY | $6.35 7.63% 6.94% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 1.07% H: 3.28% C: -1.69%

therapeutics relay
Nabriva Therapeutics to Report Third Quarter 2022 Financial Results and Recent Corporate Highlights on November 10, 2022
Published: 2022-11-07 (Crawled : 12:20) - globenewswire.com
NBRV | $1.42 1.39% 720K twitter stocktwits trandingview |
Health Technology
| | O: -1.75% H: 8.18% C: 4.35%

report therapeutics financial results
Verve Therapeutics Provides Regulatory Update on VERVE-101 Investigational New Drug Application and Reports Third Quarter 2022 Financial Results
Published: 2022-11-07 (Crawled : 12:00) - globenewswire.com
VERV | $6.58 -4.36% -4.4% 1M twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -21.87% H: 7.37% C: -11.04%

verve-101 drug application therapeutics financial update results
Beam Therapeutics Announces Portfolio Progress and Reports Third Quarter 2022 Financial Results
Published: 2022-11-07 (Crawled : 12:00) - globenewswire.com
BEAM | $22.74 -3.11% -3.21% 740K twitter stocktwits trandingview |
Health Technology
| | O: -8.88% H: 1.33% C: -2.79%

therapeutics financial results
Alterity Therapeutics Announces Presentation of Data from the bioMUSE Natural History Study at the American Autonomic Society Annual Meeting
Published: 2022-11-07 (Crawled : 03:00) - alteritytherapeutics.com
ATHE | $2.33 9.39% 8.58% 170K twitter stocktwits trandingview |
Health Technology
| | O: 2.78% H: 1.08% C: 1.08%

meeting therapeutics presentation study
Gainers vs Losers
61% 39%

Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M twitter stocktwits trandingview |
Consumer Services

BOF | $2.08 77.78% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.54 12.27% 40.62% 3.7M twitter stocktwits trandingview |

LICN | $0.999 78.39% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.4 70.0% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.6 60.71% 38.04% 9.1M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.458 14.5% 30.92% 91K twitter stocktwits trandingview |
Health Services

WHLM | $6.25 35.87% 28.46% 700K twitter stocktwits trandingview |
Commercial Services

MULN | News | $3.77 38.1% 27.78% 13M twitter stocktwits trandingview |
Information


Your saved searches
Save your searches and get alerts when important news are released.